HCA Healthcare oversold on Medicare-For-All 'noise,' says Jefferies
Jefferies analyst Brian Tanquilut says HCA Healthcare shares are now oversold amid the Medicare-For-All "noise." The analyst expects volatility in the stocks of healthcare providers before the November 2020 elections, but he believes the emergence of Medicare for All "as an early hot topic has brought volatility/noise prematurely." HCA is now oversold based on a valuation analysis that looks at previous election cycles, especially since Medicare-For-All does not pose existential risk to the hospitals, Tanquilut tells investors in a research note. As currently proposed, Medicare-For-All will most likely reduce the need for managed care companies, but the need for healthcare providers does not go away, as the government will need hospitals, physician practices, and other providers to remain viable to protect access to care, says the analyst. He keeps a Buy rating on HCA Healthcare with a $158 price target.